Diplegia (Cerebral Palsy)
For children with spastic diplegia, early diagnosis using standardized neurological assessments combined with MRI should be followed by immediate referral to intensive physical therapy and consideration of botulinum toxin A injections for focal spasticity management, with the goal of optimizing motor function and preventing secondary complications like hip displacement.
Diagnostic Approach
Early Detection (Before Age 2)
The diagnosis of diplegia—a bilateral spastic cerebral palsy pattern where lower limbs are more affected than upper limbs—requires a systematic evaluation approach 1:
Before 5 months corrected age, use:
- Prechtl Qualitative Assessment of General Movements (98% sensitivity)
- Hammersmith Infant Neurological Examination (90% sensitivity)
- Term-age MRI (86-89% sensitivity)
After 5 months corrected age, use:
- MRI (86-89% sensitivity) where feasible
- Hammersmith Infant Neurological Examination (90% sensitivity)
- Developmental Assessment of Young Children (83% C index)
Key Clinical Features to Identify
Diplegia represents approximately 37% of spastic cerebral palsy cases and manifests as lower limb spasticity greater than upper limb involvement 1. Critical point: Diagnosis typically occurs between 12-24 months, but earlier detection using the above tools allows for intervention during peak neuroplasticity periods.
Mandatory Comorbidity Screening
Screen systematically for common associated conditions that directly impact morbidity and quality of life 1:
- Hip displacement (28% prevalence) - requires surveillance imaging
- Chronic pain (75% prevalence)
- Epilepsy (35% prevalence)
- Intellectual disability (49% prevalence)
- Sleep disorders (23% prevalence)
Treatment Algorithm
First-Line: Intensive Physical Therapy
Initiate immediately upon diagnosis to capitalize on infant motor and cognitive plasticity 1. The evidence supports:
- Constraint-induced movement therapy (CIMT) may improve bimanual function when compared to low-dose therapy, though not superior to high-dose alternative therapies 2
- Sustained stretching with bracing or serial casting is more effective than stretching alone 2
- Strengthening exercises do NOT worsen spasticity (contrary to historical concerns) 2
Common pitfall: Delaying therapy while "waiting to see" how the child develops wastes critical neuroplasticity windows.
Second-Line: Focal Spasticity Management
Botulinum toxin A injections have Level A evidence for both upper and lower limb spasticity 2:
- Dosing: Product-specific (onabotulinumtoxinA, abobotulinumtoxinA, incobotulinumtoxinA are NOT interchangeable)
- Target muscles: Lower limb muscles causing functional impairment (e.g., gastrocnemius for equinus gait)
- Timing: Use as adjunct to physical therapy to facilitate motor learning
- Evidence: Significantly improves Modified Ashworth Scale scores and 10-Meter Walk Test performance 2
Alternative when cost-prohibitive: Phenol or alcohol nerve blocks (3-6% phenol concentration) can be used for proximal nerves, reserving botulinum toxin for distal musculature 2. However, this carries higher risk of dysesthesia and is SORT C evidence.
Adjunctive Modalities
Neuromuscular electrical stimulation (NMES) may temporarily reduce spasticity when combined with active therapy 2. Kinesio taping shows some benefit for normalizing muscle tone 2.
Avoid: Acupuncture and TENS have insufficient evidence as standalone or adjunct therapies 2.
Surgical Interventions
Consider surgical options when conservative management fails:
For ambulatory children (GMFCS II-III) with spastic diplegia:
- Selective dorsal rhizotomy (SDR) offers sustained spasticity reduction 3
- Timing consideration: Some advocate for staged multilevel interventions during childhood development ("SMILE" approach) rather than waiting until age 8-10 4
For hip surveillance: Progressive hip displacement requires early detection and intervention to prevent dislocation and salvage procedures 5. Hip surveillance programs reduce dislocation rates and need for salvage surgery.
Orthopedic procedures: Combined pelvic and femoral osteotomies achieve better outcomes than isolated procedures when hip displacement occurs 5.
Systemic Spasticity Management
Intrathecal baclofen (ITB) via implanted pump effectively reduces generalized spasticity and dystonia 3, but monitor for:
- Infection risk
- Potential scoliosis progression
- Pump malfunction
Functional Prognosis
In high-income countries with appropriate intervention 1:
- 2 in 3 will walk independently
- 3 in 4 will develop functional communication
- 1 in 2 will have normal intelligence
Critical caveat: These outcomes depend heavily on early diagnosis and immediate intervention. Delayed treatment reduces functional potential and increases secondary complications.
Implementation Strategy
- Immediate: Refer to specialized physical therapy upon diagnostic suspicion
- Within 3 months: Establish botulinum toxin injection schedule if focal spasticity impairs function
- Ongoing: Hip surveillance imaging every 6-12 months depending on GMFCS level
- Annual: Comprehensive reassessment of comorbidities (pain, sleep, seizures)
- As needed: Orthopedic surgery consultation for progressive deformities
The evidence strongly supports aggressive early intervention over watchful waiting, as neuroplasticity decreases with age and secondary musculoskeletal complications become increasingly difficult to reverse 1.